Squarepoint’s Molecular Templates, Inc. MTEM Stock Holding History

Squarepoint’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,512	Closed	-$89K	–	3744
2021 Q4	$89K	Buy	+1,512	New	+$113K	﹤0.01%	2948
2021 Q2	–	Sell	-1,898	Closed	-$359K	–	3862
2021 Q1	$359K	Sell	1,898 -3,948	-68%	-$692K	﹤0.01%	2272
2020 Q4	$823K	Buy	5,846 +2,828	+94%	+$418K	0.01%	1459
2020 Q3	$494K	Sell	3,018 -597	-17%	-$106K	0.01%	1445
2020 Q2	$748K	Buy	3,615 +2,628	+266%	+$611K	0.01%	1095
2020 Q1	$197K	Buy	+987	New	+$216K	0.01%	1483
2019 Q4	–	Sell	-709	Closed	-$70K	–	2906
2019 Q3	$70K	Buy	+709	New	+$66.1K	﹤0.01%	2220
2018 Q2	–	Sell	-740	Closed	-$89K	–	2138
2018 Q1	$89K	Buy	+740	New	+$111K	﹤0.01%	1582
2016 Q3	–	Sell	-395	Closed	-$41K	–	1324
2016 Q2	$41K	Buy	+395	New	+$28.3K	﹤0.01%	1038
2016 Q1	–	Sell	-681	Closed	-$54K	–	1512
2015 Q4	$54K	Buy	+681	New	+$336K	0.01%	1184

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's MTEM Position: Q1 2022 in Review

Squarepoint sold out of Molecular Templates, Inc. (MTEM) in Q1 2022, closing a stake of 1,512 shares — an estimated $89K sold.

Squarepoint first reported a position in MTEM in Q4 2015 and held it in 10 quarters. The position peaked at $823K in Q4 2020. 77 funds tracked by Wall St. Rank hold MTEM as of Q1 2022.

Squarepoint reported no remaining Molecular Templates, Inc. position as of Q1 2022 after selling out during the quarter.
Squarepoint sold 1,512 Molecular Templates, Inc. shares in Q1 2022, an estimated $89K.
Squarepoint first reported a position in Molecular Templates, Inc. in Q4 2015 and held it in 10 quarters.
Squarepoint's Molecular Templates, Inc. position peaked at $823K in Q4 2020.
77 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.